Skip to main content
Hematology and Oncology
ALL Specialities
ALL Specialities
/
Hematology and Oncology
Blood & Cancer Podcast
CME
Diseases & Conditions
Nonmalignant Hematologic Disorders
Anemia
Bleeding Disorders
Thrombosis
Breast Cancer
CNS/Brain Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Renal Cell Carcinoma
Gynecologic Cancer
Head & Neck/Thyroid Cancers
Leukemia, Myelodysplasia, Transplantation
ALL
AML
Cellular Therapy
CLL
CML
Myelodysplastic Syndrome
Transplantation
Lung Cancer
Lymphoma & Plasma Cell Disorders
B Cell Lymphoma
Follicular Lymphoma
Hodgkin Lymphoma
Mantle Cell Lymphoma
Multiple Myeloma
Non-Hodgkin Lymphoma
T Cell Lymphomas
Melanoma
Nonmelanoma Skin Cancer
Sarcoma and GIST
COVID-19 Updates
Conference Coverage
News
New online tool helps estimate ‘true’ drug cost
Publish date:
September 9, 2015
References
wmcknight@frontlinemedcom.com
On Twitter
@whitneymcknight
Pages
« first
1
2
Recommended Reading
Re-personalizing precision medicine: is there a role for patient-reported outcomes?
MDedge Hematology and Oncology
Lung cancer in HIV-infected patients and the role of targeted therapy
MDedge Hematology and Oncology
Life-threatening hypoglycemia resulting from a nonislet cell tumor
MDedge Hematology and Oncology
Drug-induced immune hemolytic anemia associated with albumin-bound paclitaxel
MDedge Hematology and Oncology
Expert argues for change in the way biomarkers are evaluated
MDedge Hematology and Oncology
ED care pathway hastens febrile neutropenia therapy
MDedge Hematology and Oncology
Community cancer programs best for psychosocial care
MDedge Hematology and Oncology
Pruritus prophylaxis appropriate for targeted cancer therapies
MDedge Hematology and Oncology
FDA approves aprepitant for 12- to 17-year-olds
MDedge Hematology and Oncology
FDA approves antiemesis drug rolapitant
MDedge Hematology and Oncology
Patient & Survivor Care
Practice Management
Business of Medicine
All Specialties
